Human c1-esterase inhibitor
- Part D specialty tier in 77% of formularies (2026Q3)
- Cinryze
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Human c1-esterase inhibitor: storage and handling
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- No allowance stated
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (4)
- CINRYZE, packaged for sale, is stable for 24 months when stored at 2°C–25°C (36°F-77°F).
- Do not freeze.
- Store the vial in the original carton to protect it from light.
- Do not use beyond the expiration date on the CINRYZE vial.
FDA label version 10, effective November 1, 2010. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.